MCMedicalCodingSoftware
123

MS-DRG 123: NEUROLOGICAL EYE DISORDERS

DRGMedicalMDC 02

MS-DRG 123 is neurological eye disorders, in MDC 02 (a medical DRG). Its FY2027 relative weight is 0.8220, so a case here pays less than the average Medicare inpatient stay (weight 1.0), with a geometric mean length of stay of 2.00 days. 210 ICD-10-CM principal diagnoses group into MS-DRG 123 under the CMS definitions manual; the most-searched are listed below.

FY2027 payment factors

Relative weight
0.8220
Geometric mean LOS
2.00
Arithmetic mean LOS
2.60
Post-acute transfer
No

Principal diagnoses that group to MS-DRG 123

From the CMS MS-DRG definitions manual’s principal-diagnosis index: 210 ICD-10-CM codes route here. The 24 most-searched:

  • H53.2Diplopia
  • G45.3Amaurosis fugax
  • H34.8310Tributary (branch) retinal vein occlusion, right eye, with macular edema
  • H34.8320Tributary (branch) retinal vein occlusion, left eye, with macular edema
  • H02.403Unspecified ptosis of bilateral eyelids
  • H34.8110Central retinal vein occlusion, right eye, with macular edema
  • H34.8120Central retinal vein occlusion, left eye, with macular edema
  • H02.423Myogenic ptosis of bilateral eyelids
  • H47.20Unspecified optic atrophy
  • H53.40Unspecified visual field defects
  • H55.00Unspecified nystagmus
  • H57.03Miosis
  • H02.401Unspecified ptosis of right eyelid
  • H02.402Unspecified ptosis of left eyelid
  • H02.421Myogenic ptosis of right eyelid
  • H46.9Unspecified optic neuritis
  • H53.453Other localized visual field defect, bilateral
  • A39.82Meningococcal retrobulbar neuritis
  • H02.409Unspecified ptosis of unspecified eyelid
  • H02.422Myogenic ptosis of left eyelid
  • H02.429Myogenic ptosis of unspecified eyelid
  • H02.431Paralytic ptosis of right eyelid
  • H02.432Paralytic ptosis of left eyelid
  • H02.433Paralytic ptosis of bilateral eyelids

186 more codes group here. Open any code above for its full hierarchy, or check a whole claim in the free DRG calculator.

All FY2027 MS-DRGs · MDC 02

MS-DRG (IPPS Table 5)FY2027